<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">33560155</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>15</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>03</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1559-8519</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>59</Volume>
            <Issue>4</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>May</Month>
            </PubDate>
          </JournalIssue>
          <Title>Journal of sex research</Title>
          <ISOAbbreviation>J Sex Res</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Sexual Functioning, Satisfaction, and Well-Being Among Contraceptive Users: A Three-Month Assessment From the HER Salt Lake Contraceptive Initiative.</ArticleTitle>
        <Pagination>
          <StartPage>435</StartPage>
          <EndPage>444</EndPage>
          <MedlinePgn>435-444</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1080/00224499.2021.1873225</ELocationID>
        <Abstract>
          <AbstractText>Few large, longitudinal studies document multiple contraceptive methods' effects on sexual functioning, satisfaction, and well-being. We leveraged data from the HER Salt Lake Contraceptive Initiative, a prospective cohort study with patient surveys at baseline, one month, and three months. Surveys assessed bleeding changes, contraceptive-related side effects, sexual functioning and satisfaction, and perceptions of methods' impact on sexual well-being. Individuals in the final sample (<i>N =</i> 2,157) initiated either combined oral contraceptives, levonorgestrel intrauterine devices (IUDs), copper IUDs, implants, injectables, or vaginal rings. Across methods, participants exhibited minimal changes in sexual function (Female Sexual Function Index-6 scores) or satisfaction (New Scale of Sexual Satisfaction scores) over three months. However, many perceived contraception-related changes to sexual well-being. Half (51%) reported their new method had made their sex life better; 15% reported it had made their sex life worse. Sexual improvements were associated with decreased vaginal bleeding, fewer side effects, and IUD use. Negative sexual impacts were associated with physical side effects (e.g., bloating and breast tenderness), increased bleeding, and vaginal ring use. In conclusion, contraceptive users did not experience major changes in sexual functioning or satisfaction over three months, but they did report subjective sexual changes, mostly positive, due to their method.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Higgins</LastName>
            <ForeName>Jenny A</ForeName>
            <Initials>JA</Initials>
            <AffiliationInfo>
              <Affiliation>Departments of Obstetrics and Gynecology and Gender and Women's Studies, University of Wisconsin.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kramer</LastName>
            <ForeName>Renee D</ForeName>
            <Initials>RD</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Population Health Sciences, University of Wisconsin.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wright</LastName>
            <ForeName>Kelsey Q</ForeName>
            <Initials>KQ</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Sociology, University of Wisconsin.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Everett</LastName>
            <ForeName>Bethany</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Sociology, University of Utah.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Obstetrics and Gynecology, University of Utah.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Turok</LastName>
            <ForeName>David K</ForeName>
            <Initials>DK</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Obstetrics and Gynecology, University of Utah.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sanders</LastName>
            <ForeName>Jessica N</ForeName>
            <Initials>JN</Initials>
            <Identifier Source="ORCID">0000-0002-4487-1997</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Obstetrics and Gynecology, University of Utah.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>K01 HS027220</GrantID>
            <Acronym>HS</Acronym>
            <Agency>AHRQ HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>UL1 RR025764</GrantID>
            <Acronym>RR</Acronym>
            <Agency>NCRR NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>K12 HD055894</GrantID>
            <Acronym>HD</Acronym>
            <Agency>NICHD NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>K12 HD085852</GrantID>
            <Acronym>HD</Acronym>
            <Agency>NICHD NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>P2C HD047873</GrantID>
            <Acronym>HD</Acronym>
            <Agency>NICHD NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>UL1 TR000105</GrantID>
            <Acronym>TR</Acronym>
            <Agency>NCATS NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R01 HD095661</GrantID>
            <Acronym>HD</Acronym>
            <Agency>NICHD NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>T32 HD007014</GrantID>
            <Acronym>HD</Acronym>
            <Agency>NICHD NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2021</Year>
          <Month>02</Month>
          <Day>09</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>J Sex Res</MedlineTA>
        <NlmUniqueID>0062647</NlmUniqueID>
        <ISSNLinking>0022-4499</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D003270">Contraceptive Agents</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D003267" MajorTopicYN="N">Contraception</DescriptorName>
          <QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003270" MajorTopicYN="Y">Contraceptive Agents</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007434" MajorTopicYN="Y">Intrauterine Devices</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010549" MajorTopicYN="N">Personal Satisfaction</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2021</Year>
          <Month>2</Month>
          <Day>10</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>16</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2021</Year>
          <Month>2</Month>
          <Day>9</Day>
          <Hour>12</Hour>
          <Minute>9</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">33560155</ArticleId>
        <ArticleId IdType="mid">NIHMS1664541</ArticleId>
        <ArticleId IdType="pmc">PMC8349922</ArticleId>
        <ArticleId IdType="doi">10.1080/00224499.2021.1873225</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Bancroft J, &amp; Graham CA (2011). The varied nature of women’s sexuality: Unresolved issues and a theoretical approach. Hormones and Behavior, 59(5), 717–729. 10.1016/j.yhbeh.2011.01.005</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.yhbeh.2011.01.005</ArticleId>
            <ArticleId IdType="pubmed">21272585</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bastianelli C, Farris M, &amp; Benagiano G (2011). Use of the levonorgestrel-releasing intrauterine system, quality of life and sexuality: Experience in an Italian family planning center. Contraception, 84 (4), 402–408. 10.1016/j.contraception.2011.01.020</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.contraception.2011.01.020</ArticleId>
            <ArticleId IdType="pubmed">21920196</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Both S, Lew-Starowicz M, Luria M, Sartorius G, Maseroli E, Tripodi F, Lowenstein L, Nappi RE, Corona G, Reisman Y, &amp; Vignozzi L (2019). Hormonal contraception and female sexuality: Position statements from the European Society of Sexual Medicine (ESSM). Journal of Sexual Medicine, 16(11), 1681–1695. 10.1016/j.jsxm.2019.08.005</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jsxm.2019.08.005</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Braher E, Muhlan H, Albani C, &amp; Schmidt S (2007). Testing and standardization of the German version of the EUROHIS-QOL and WHO-5 quality-of life indices. Diagnostica, 53(2), 83–96. 10.1026/0012-1924.53.2.83</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1026/0012-1924.53.2.83</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Burrows LJ, Basha M, &amp; Goldstein AT (2012). The effects of hormonal contraceptives on female sexuality: A review. Journal of Sexual Medicine, 9(9), 2213–2223. 10.1111/j.1743-6109.2012.02848.x</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1743-6109.2012.02848.x</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Caruso S, Cianci S, Malandrino C, Cicero C, Lo Presti L, &amp; Cianci A (2014). Quality of sexual life of women using the contraceptive vaginal ring in extended cycles: Preliminary report. European Journal of Contraception and Reproductive Health Care, 19(4), 307–314. 10.3109/13625187.2014.914488</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3109/13625187.2014.914488</ArticleId>
            <ArticleId IdType="pubmed">24856308</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chesney MA, &amp; Tasto DL (1975). The development of the Menstrual Symptom Questionnaire. Behaviour Research and Therapy, 13(4), 237–244. 10.1016/0005-7967(75)90028-5</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0005-7967(75)90028-5</ArticleId>
            <ArticleId IdType="pubmed">1238078</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Davis AR, &amp; Castano PM (2004). Oral contraceptives and libido in women. Annual Review of Sex Research, 15(1), 297–320. 10.1080/10532528.2004.10559822</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/10532528.2004.10559822</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dehlendorf C, Levy K, Kelley A, Grumbach K, &amp; Steinauer J (2013). Women’s preferences for contraceptive counseling and decision making. Contraception, 88(2), 250–256. 10.1016/j.contraception.2012.10.012</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.contraception.2012.10.012</ArticleId>
            <ArticleId IdType="pmc">PMC4026257</ArticleId>
            <ArticleId IdType="pubmed">23177265</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Diedrich JT, Zhao Q, Madden T, Secura GM, &amp; Peipert JF (2015). Three-year continuation of reversible contraception. American Journal of Obstetrics and Gynecology, 213(5), 662
e661–668.
10.1016/j.ajog.2015.08.001</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ajog.2015.08.001</ArticleId>
            <ArticleId IdType="pmc">PMC5292132</ArticleId>
            <ArticleId IdType="pubmed">26259905</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gomez AM, &amp; Clark JB (2014). The relationship between contraceptive features preferred by young women and interest in IUDs: An exploratory analysis. Perspectives on Sexual and Reproductive Health, 46(3), 157–163. 10.1363/46e2014</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1363/46e2014</ArticleId>
            <ArticleId IdType="pubmed">25040577</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gorgen H, Api M, Akca A, &amp; Cetin A (2009). Use of the Levonorgestrel-IUS in the treatment of menorrhagia: Assessment of quality of life in Turkish users. Archives of Gynecology and Obstetrics, 279(6), 835–840. 10.1007/s00404-008-0834-x</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00404-008-0834-x</ArticleId>
            <ArticleId IdType="pubmed">19018547</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Graham CA, Bancroft J, Doll HA, Greco T, &amp; Tanner A (2007). Does oral contraceptive-induced reduction in free testosterone adversely affect the sexuality or mood of women?
Psychoneuroendocrinology, 32(3), 246–255. 10.1016/j.psyneuen.2006.12.011</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.psyneuen.2006.12.011</ArticleId>
            <ArticleId IdType="pubmed">17314012</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Graham CA, Ramos R, Bancroft J, Maglaya C, &amp; Farley TM (1995). The effects of steroidal contraceptives on the well-being and sexuality of women: A double-blind, placebo-controlled, two-centre study of combined and progestogen-only methods. Contraception, 52 (6), 363–369. 10.1016/0010-7824(95)00226-x</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0010-7824(95)00226-x</ArticleId>
            <ArticleId IdType="pubmed">8749600</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gubrium A (2011). “I’ve lost my mojo, baby”: A narrative perspective on the effect of Depo-Provera on libido. Sexuality Research and Social Policy, 8(4), 321–334. 10.1007/s13178-011-0055-0</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s13178-011-0055-0</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, &amp; Conde JG (2009). Research electronic data capture (REDCap): A metadata-driven methodology and workflow process for providing translational research informatics support. Journal of Biomedical Informatics, 42 (2), 377–381. 10.1016/j.jbi.2008.08.010</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jbi.2008.08.010</ArticleId>
            <ArticleId IdType="pmc">PMC2700030</ArticleId>
            <ArticleId IdType="pubmed">18929686</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Higgins JA, &amp; Hirsch JS (2007). The pleasure deficit: Revisiting the “sexuality connection” in reproductive health. Perspectives on Sexual and Reproductive Health, 39(4), 240–247. 10.1363/3924007</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1363/3924007</ArticleId>
            <ArticleId IdType="pubmed">18093041</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Higgins JA, &amp; Hirsch JS (2008). Pleasure, power, and inequality: Incorporating sexuality into research on contraceptive use. American Journal of Public Health, 98(10), 1803–1813. 10.2105/ajph.2007.115790</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2105/ajph.2007.115790</ArticleId>
            <ArticleId IdType="pmc">PMC2636476</ArticleId>
            <ArticleId IdType="pubmed">18703457</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Higgins JA, Kramer RD, Everett B, Wright KQ, Turok DK, &amp; Sanders JN (n.d.). Examining associations between perceptions of contraceptive methods’ sexual impacts and use over time. Manuscript under review.</Citation>
        </Reference>
        <Reference>
          <Citation>Higgins JA, Ryder K, Skarda G, Koepsel E, &amp; Bennett EA (2015). The sexual acceptability of intrauterine contraception: A qualitative study of young adult women. Perspectives on Sexual and Reproductive Health, 47(3), 115–122. 10.1363/47e4515</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1363/47e4515</ArticleId>
            <ArticleId IdType="pmc">PMC4573918</ArticleId>
            <ArticleId IdType="pubmed">26280666</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Higgins JA, Sanders JN, Palta M, &amp; Turok DK (2016). Women’s sexual function, satisfaction, and perceptions after starting long-acting reversible contraceptives. Obstetrcis and Gynecology, 128(5), 1143–1151. 10.1097/AOG.0000000000001655</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/AOG.0000000000001655</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Higgins JA, &amp; Smith NK (2016). The sexual acceptability of contraception: Reviewing the literature and building a new concept. Journal of Sex Research, 53(4–5), 417–456. 10.1080/00224499.2015.1134425</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/00224499.2015.1134425</ArticleId>
            <ArticleId IdType="pmc">PMC4868075</ArticleId>
            <ArticleId IdType="pubmed">26954608</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Higgins JA, Wright KQ, Everett BG, Kramer RD, Turok DK, &amp; Sanders JN (2020). Sexual impacts, not just side effects, drive contraceptive use: How sexual outcomes at one month affect contraceptive continuation [manuscript submitted for publication]. Departments of Gender and Women’s Studies and Obstetrics and Gynecology, University of Wisconsin-Madison.</Citation>
        </Reference>
        <Reference>
          <Citation>Isidori AM, Pozza C, Esposito K, Giugliano D, Morano S, Vignozzi L, &amp; Jannini EA (2010). Development and validation of a 6-item version of the Female Sexual Function Index (FSFI) as a diagnostic tool for female sexual dysfunction. Journal of Sexual Medicine, 7(3), 1139–1146. 10.1111/j.1743-6109.2009.01635.x</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1743-6109.2009.01635.x</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Landers S, &amp; Kapadia F (2020). The public health of pleasure: Going beyond disease prevention. American Journal of Public Health, 110(2), 140–141. 10.2105/AJPH.2019.305495</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2105/AJPH.2019.305495</ArticleId>
            <ArticleId IdType="pmc">PMC6951379</ArticleId>
            <ArticleId IdType="pubmed">31913667</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lessard LN, Karasek D, Ma S, Darney P, Deardorff J, Lahiff M, Grossman D, &amp; Foster DG (2012). Contraceptive features preferred by women at high risk of unintended pregnancy. Perspectives on Sexual and Reproductive Health, 44(3), 194–200. 10.1363/4419412</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1363/4419412</ArticleId>
            <ArticleId IdType="pubmed">22958664</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Negriff S, Dorn LD, Hillman JB, &amp; Huang B (2009). The measurement of menstrual symptoms: Factor structure of the Menstrual Symptom Questionnaire in adolescent girls. Journal of Health Psychology, 14(7), 899–908. 10.1177/1359105309340995</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/1359105309340995</ArticleId>
            <ArticleId IdType="pmc">PMC4301608</ArticleId>
            <ArticleId IdType="pubmed">19786516</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>O’Neil-Callahan M, Peipert JF, Zhao Q, Madden T, &amp; Secura G (2013). Twenty-four-month continuation of reversible contraception. Obstetrics and Gynecology, 122(5), 1083–1091. 10.1097/AOG.0b013e3182a91f45</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/AOG.0b013e3182a91f45</ArticleId>
            <ArticleId IdType="pmc">PMC4012225</ArticleId>
            <ArticleId IdType="pubmed">24104781</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Peipert JF, Zhao Q, Allsworth JE, Petrosky E, Madden T, Eisenberg D, &amp; Secura G (2011). Continuation and satisfaction of reversible contraception. Obstetrics and Gynecology, 117(5), 1105–1113. 10.1097/AOG.0b013e31821188ad</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/AOG.0b013e31821188ad</ArticleId>
            <ArticleId IdType="pmc">PMC3548669</ArticleId>
            <ArticleId IdType="pubmed">21508749</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pinar SE, Demirel G, Yildirim G, &amp; Daglar G (2019). Sexual experiences and quality of life in Turkish women using methods of contraception. Journal of Obstetrics and Gynaecology, 39(6), 782–787. 10.1080/01443615.2019.1581738</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/01443615.2019.1581738</ArticleId>
            <ArticleId IdType="pubmed">31020887</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pitts RA, &amp; Greene RE (2020). Promoting positive sexual health. American Journal of Public Health, 110(2), 149–150. 10.2105/AJPH.2019.305336</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2105/AJPH.2019.305336</ArticleId>
            <ArticleId IdType="pmc">PMC6951384</ArticleId>
            <ArticleId IdType="pubmed">31913675</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Price DD, Finniss DG, &amp; Benedetti F (2008). A comprehensive review of the placebo effect: Recent advances and current thought. Annual Review of Psychology, 59(1), 565–590. 10.1146/annurev.psych.59.113006.095941</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1146/annurev.psych.59.113006.095941</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rosen R, Brown C, Heiman J, Leiblum S, Meston C, Shabsigh R, &amp; D’Agostino R Jr. (2000). The Female Sexual Function Index (FSFI): A multidimensional self-report instrument for the assessment of female sexual function. Journal of Sex and Marital Therapy, 26(2), 191–208. 10.1080/009262300278597</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/009262300278597</ArticleId>
            <ArticleId IdType="pubmed">10782451</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sanders JN, Adkins DE, Kaur S, Storck K, Gawron LM, &amp; Turok DK (2018). Bleeding, cramping, and satisfaction among new copper IUD users: A prospective study. PLoS ONE, 13(11), e0199724. 10.1371/journal.pone.0199724</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0199724</ArticleId>
            <ArticleId IdType="pmc">PMC6221252</ArticleId>
            <ArticleId IdType="pubmed">30403671</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sanders JN, Myers K, Gawron LM, Simmons RG, &amp; Turok DK (2018). Contraceptive method use during the community-wide HER salt lake contraceptive initiative. American Journal of Public Health, 108 (4), 550–556. 10.2105/AJPH.2017.304299</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2105/AJPH.2017.304299</ArticleId>
            <ArticleId IdType="pmc">PMC5844407</ArticleId>
            <ArticleId IdType="pubmed">29470119</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sanders SA, Graham CA, Bass JL, &amp; Bancroft J (2001). A prospective study of the effects of oral contraceptives on sexuality and well-being and their relationship to discontinuation. Contraception, 64(1), 51–58. 10.1016/S0010-7824(01)00218-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0010-7824(01)00218-9</ArticleId>
            <ArticleId IdType="pubmed">11535214</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schaffir J (2006). Hormonal contraception and sexual desire: A critical review. Journal of Sex and Marital Therapy, 32(4), 305–314. 10.1080/00926230600666311</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/00926230600666311</ArticleId>
            <ArticleId IdType="pubmed">16709551</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Severy LJ, &amp; Newcomer S (2005). Critical issues in contraceptive and STI acceptability research. Journal of Social Issues, 61(1), 45–65. 10.1111/j.0022-4537.2005.00393.x</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.0022-4537.2005.00393.x</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>StataCorp. (2017). Stata statistical software: Release 15.</Citation>
        </Reference>
        <Reference>
          <Citation>Stulhofer A, Busko V, &amp; Brouillard P (2010). Development and bicultural validation of the new Sexual Satisfaction Scale. Journal of Sex Research, 47(4), 257–268. 10.1080/00224490903100561</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/00224490903100561</ArticleId>
            <ArticleId IdType="pubmed">19629836</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wanyonyi S, Stones W, &amp; Sequeira E (2011). Health-related quality of life changes among users of depot medroxyprogesterone acetate for contraception. Contraception, 84(5), e17–e22. 10.1016/j.contraception.2011.05.022</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.contraception.2011.05.022</ArticleId>
            <ArticleId IdType="pubmed">22018133</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Welling LL (2013). Psychobehavioral effects of hormonal contraceptive use. Evolutionary Psychology, 11(3), 718–742. 10.1177/147470491301100315</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/147470491301100315</ArticleId>
            <ArticleId IdType="pubmed">23864301</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
